title: Pharmaceutical laws and regulations in Iran: An overview.
abstract: The pharmaceutical legal framework is a very important infrastructure in achieving predefined goals in pharmaceutical sector: Accessibility, quality, and rational use of medicine. This study aims to review the current pharmaceutical sector-related legal provisions in Iran where the Food and Drug Organization (FDO) is in charge of regulating all issues related to the pharmaceutical sector. The main laws and regulations enacted by parliament and cabinet and even internal regulations enacted by the Ministry of Health or Iran FDO are reviewed. Different laws and regulations are categorized according to the main goals of Iran national drug policy.
authors: Pharmaceutical Management and Economics Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors: Pardis
authors: P
authors: Zaboli
authors: Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran University of Medical Sciences, Tehran, Iran.
authors: Amir
authors: A
authors: Hashemi-Meshkini
authors: Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran University of Medical Sciences, Tehran, Iran.
authors: Mehdi
authors: M
authors: Varmaghani
authors: Department of Pharmaceutics, Tehran University of Medical Sciences, Tehran, Iran.
authors: Hadi
authors: H
authors: Gholami
authors: Department of Pharmaceutics, Tehran University of Medical Sciences, Tehran, Iran.
authors: Iman
authors: I
authors: Vazirian
authors: Department of Economics, Shahid Beheshti University, Tehran, Iran.
authors: Hedieh-Sadat
authors: HS
authors: Zekri
authors: Department of Pharmaceutics, Tehran University of Medical Sciences, Tehran, Iran.
authors: Shahriar
authors: S
authors: Eslamitabar
authors: Pharmaceutical Management and Economics Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran University of Medical Sciences, Tehran, Iran.
authors: Abbas
authors: A
authors: Kebriaeezadeh
keywords: Accessibility; availability; counterfeit medicines; pharmaceutical trade-related aspects; rational use of medicine